Akari Therapeutics, Plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 02/14/2024 | 164,026 | $511,761 | -7.90% | 0.26% |
| CORNERSTONE PLANNING GROUP LLC | 02/12/2024 | 5 | $16 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Akari Therapeutics, Plc institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Akari Therapeutics, Plc. The most heavily invested institutionals were:
Advisor Group, Inc.: 1,029
Virtu KCG Holdings LLC: 12,472
VHCP Management, LLC: 158,352
0.26% of Akari Therapeutics, Plc stock is owned by institutional investors.
Institutional investors have bought a total of 171,853 shares in the last 24 months. This purchase volume represents approximately $237,157 in transactions.